APPENDIX C
Workshop Agenda
INSTITUTE OF MEDICINE
NATIONAL ACADEMY OF SCIENCES
FORUM ON EMERGING INFECTIONS
Managed Care Systems and Emerging Infections:
Opportunities for Strengthening Surveillance,
Research, and Prevention
March 23–24, 1998
MONDAY, MARCH 23, 1998 |
|
8:00 a.m. |
Continental Breakfast |
8:30 |
Welcome and Opening Remarks Joshua Lederberg, Ph.D. Chair, Forum on Emerging Infections |
8:45 |
Keynote Address Margaret Hamburg, M.D. Assistant Secretary for Planning and Evaluation U.S. Department of Health and Human Services |
9:00–11:00 |
PANEL I: BASIC AND CLINICAL RESEARCH Moderator: Frederick Sparling, M.D., Forum Member |
9:00 |
AAMC Perspective on Basic and Clinical Research David Korn, M.D. Senior Vice President for Biomedical and Health Science Research Association of American Medical Colleges |
|
Opportunities for Population-Based Clinical Research Using Data from Managed Care Organizations Frank DeStefano, M.D., M.P.H. Medical Epidemiologist, Vaccine Safety and Development Activity National Immunization Program, Centers for Disease Control and Prevention |
|
Conducting Clinical Research Within Managed Care Organizations Walter Stamm, M.D. Professor of Medicine and Head, Division of Allergy and Infectious Diseases University of Washington School of Medicine |
|
Clinical Research: The Challenge or Promise of Managed Care Lana Skirboll, Ph.D. Associate Director, Office of Science Policy National Institutes of Health |
9:45 |
Discussion |
10:50 |
Break |
11:00 a.m.–1:00 p.m. PANEL II: CLINICAL PRACTICE GUIDELINES Moderator: Vincent Ahonkhai, M.D., Forum Member |
|
11:00 |
Making Guidelines Instrumental: Theory versus Practice Richard E. Dixon, M.D. Medical Director, National Independent Practice Association Coalition |
|
Realities of Implementing Guidelines Nora Morris, M.A. Assistant Director/Senior Analyst, Healthcare Education and Research Foundation, Inc. |
|
Clinical Practice Guidelines for Emerging Infections and Managed Care Anne Schuchat, M.D. Chief, Childhood and Respiratory Diseases Branch Bacterial and Mycotic Disease Division, National Center for Infectious Diseases Centers for Disease Control and Prevention |
11:30 |
Discussion and Working Lunch |
1:00–3:00 p.m. PANEL III: SURVEILLANCE AND MONITORING Moderator: Carlos Lopez, Ph.D., Forum Member |
|
1:00 |
Collaborative Surveillance Efforts and Monitoring of Data Richard Platt, M.D. Director of Research, Harvard Pilgrim Health Care of New England |
|
LDS Hospital's System John Burke, M.D. Department of Clinical Epidemiology, LDS Hospital |
|
An Employer's Perspective Thomas Davies, M.P.A., J.D. Manager of Managed Care, GTE Corporation |
|
Laboratory-Based Reporting and Managing Encounter-Level Data Richard E. Dixon, M.D. Medical Director, National Independent Practice Association |
|
Laboratory-Based Reporting Issues Robert Rubin, M.D. President and Chief Operating Officer The Lewin Group |
|
Surveillance and Monitoring: Issues at the Legal Interface René Bowser, J.D. Georgetown University Law Center |
|
Managed Care and Infectious Disease Surveillance: Opportunities for Collaboration Denise Koo, Ph.D. Director, Division of Public Health Surveillance and Informatics Epidemiology Program Office, Centers for Disease Control and Prevention |
1:40 |
Discussion |
2:50 |
Break |
3:00–4:30 p.m. PANEL IV: EDUCATION AND OUTREACH Moderator: Renu Gupta, M.D., Forum Member |
|
3:00 |
Coordinating Health Plan Research and Educational Efforts Richard Platt, M.D. Director of Research, Harvard Pilgrim Health Care of New England |
|
Perspective on Managed Care Systems' Impact on Education and Outreach from the National Center for Infectious Diseases Ben Schwartz, M.D. Deputy Director, Epidemiology and Surveillance Division National Center for Infectious Diseases, Centers for Disease Control and Prevention |
|
Education and Outreach Perspectives by the National Institute of Allergy and Infectious Diseases Karl Western Assistant Director for International Research National Institute of Allergy and Infectious Diseases National Institutes of Health |
|
Managed Care Systems and Emerging Infections: Education and Outreach William Baine, M.D. Center for Cost and Financing Studies Center for Outcomes and Effectiveness Research Agency for Health Care Policy and Research |
3:30 |
Discussion |
4:30 |
Adjournment |
TUESDAY, MARCH 24, 1998 |
|
8:00 a.m. |
Continental Breakfast |
8:30–10:00 a.m. PANEL V: DRUG FORMULARIES Moderator: David Shlaes, M.D., Ph.D., Forum Member |
8:30 |
Regulatory Issues Laurie Burke, R.Ph., M.P.H. Chief of Managed Care Outcome and Labeling, Drug Marketing, Advertising, and Communication Division Center for Drug Evaluation and Research U.S. Food and Drug Administration |
|
Relationship Between Managed Care Formularies and Treatment Outcomes Susan Horn, Ph.D. Senior Scientist, Institute for Clinical Outcomes Research Vice President of Research for International Severity Information Systems Professor of Medical Informatics, University of Utah School of Medicine |
|
Bacterial Resistance, the Antibiotic Formulary, and Other Management Strategies Jerome Schentag, Pharm. D. Director, Clinical Pharmacokinetics Laboratory Millard Fillmore Health System Professor of Pharmaceutics and Pharmacy State University of New York at Buffalo |
|
The Economics of Restrictions on Pharmaceuticals Douglas L. Cocks, Ph.D. Senior Research Scientist for Health Economics Eli Lilly & Company |
9:00 |
Discussion |
9:50 |
Break |
10:00 a.m.–12:00 noon GENERAL DISCUSSION |
|
|
General Discussion Moderator: Joshua Lederberg, Ph.D., Forum Chair |
10:00 |
Summary of Sessions by Panel Moderators Panel I: Basic and Clinical Research Frederick Sparling, M.D. Panel II: Clinical Practice Guidelines Vincent Ahonkhai, M.D. Panel III: Surveillance and Monitoring Carlos Lopez, Ph.D. Panel IV: Education and Outreach Renu Gupta, M.D. Panel V: Drug Formularies David Shlaes, M.D., Ph.D. |